Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-<i>κ</i>B into the Nucleus

<table>At 20 h after Con A injection, there were no cases of fatality in the nonpioglitazone-treated group of mice, whereas the fatality rate was 70% in the pioglitazone-treated mice.</table>

PPAR Research

fig2

Figure 2

Figure 2: Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-<i>κ</i>B into the Nucleus 

Figure 2 | Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-κB into the Nucleus 